In vitro studies of prostate cancer have shown that AKT, as an upstream regulatory hub, can directly stabilize and activate the expression and function of HIF-1α through the PI3K/AKT signaling pathway (Lee et al., 2022). Here, AKT1 is linked to prostate carcinoma.